Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Scientific Show Stopper

  • 0 Articles
  • 238 Posts

No articles were found with this tag.

  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 23
  • 24
  • Next →
Selective acetylcholine receptor modulation improves cognitive symptoms in mouse prion disease
Work led by Andrew Tobin at the University of Leicester tested two drugs that specifically target the M1 muscarinic acetylcholine receptor in a mouse model of prion disease and discovered that the treatments reversed cognitive decline.
Published December 19, 2016
Scientific Show Stopper

Golgi compaction supports metastasis initiated by epithelial-to-mesenchymal transition
Recent work by Jonathan Kurie’s lab at MD Anderson Cancer Center has shown that the epithelial-to-mesenchymal transition is accompanied a compaction of Golgi organelles that may enhance pro-metastatic vesicle trafficking...
Published November 21, 2016
Scientific Show Stopper

Adaptive vascularization in the heart after loss of hemoglobin S-nitrosylation
Work from Jonathan Stamler’s lab at Case Western Reserve University shows that S-nitrosylation plays a key role in protecting against ischemic cardiac injury and heart failure...
Published November 14, 2016
Scientific Show Stopper

Keratinocytes strike a balance in the epidermal barrier
Work led by Stephen Galli at Stanford University has determined that expression of the E3 ubiquitin ligase RAB guanine nucleotide exchange factor 1 (RABGEF1) in keratinocytes plays a crucial role in maintaining epidermal barrier function...
Published November 7, 2016
Scientific Show Stopper

Macrophages activate ovarian tumor cell proliferation and migration during metastasis
In the accompanying video, author Wang Min describes how TAMs are recruited to ovarian tumor cells in the peritoneal environment to form spheroids that drive the early stages of metastasis...
Published October 10, 2016
Scientific Show Stopper

Blocking cell cycling promotes intestinal stem cell survival after radiotherapy
Work led by Jian Yu at the University of Pittsburgh School of Medicine has demonstrated that blocking the G1/S transition with an inhibitor of cyclin-dependent kinase 4/6 protects mice against radiation-induced intestinal damage...
Published October 4, 2016
Scientific Show Stopper

ERK inhibition improves responses in radioiodine-resistant thyroid tumors
Research led by James Fagin at Memorial Sloan Kettering has demonstrated that potent, sustained ERK inhibition leads to greater improvements in the clinical response to radioiodine therapy in resistant tumors...
Published September 26, 2016
Scientific Show Stopper

E2F8 keeps liver cancer at bay
Alain de Bruin, Gustavo Leone, and colleagues find that the E2F8-mediated transcriptional repression in the developing liver suppresses hepatocellular carcinoma later in life …
Published July 25, 2016
Scientific Show StopperOncology

TBX4 paves the way for lung fibrosis
Xie and colleagues demonstrate that the transcription factor TBX4 contributes to pathogenic fibroblast accumulation during lung fibrosis by providing cellular progenitors and enhancing fibroblast invasiveness…
Published July 11, 2016
Scientific Show Stopper

Exosome delivery promotes allograft rejection
Quan Lui and colleagues reveal that delivery of donor MHC-containing exosomes from donor DCs to recipient DCs drive allograft-targeting immune responses…
Published June 27, 2016
Scientific Show StopperImmunology
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 23
  • 24
  • Next →
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts